Welcome to Hmobio!Global leader in active molecules.
Find Your Distributors

Select Your Country or Region

$ USD

You are here:Home-Inhibitors & Agonists-Antibiotics and Antivirals-Parasite

Request The Product List ofParasite Parasite

Parasites are eukaryotic pathogenic organisms belonging to protozoa (unicellular organisms) or metazoa (multicellular animals). Parasitism is a subtype of symbiosis, in which one of the symbionts (parasite) benefits from the coexistence and the other one (host) is adversely affected. The disservice to the host, however, is debatable in many parasitic infections. Typically, it does not benefit the parasite if the host becomes unwell or even dies. On the other hand, it is often more beneficial for the host to tolerate a moderate number of parasites that do little harm than to strive after a parasite-free state, which would demand a disproportional immunological effort. Many dog owners believe that a single parasite can adversely affect the dog’s welfare and thus cannot be tolerated. This is part of the reason that parasite diagnostics and antiparasitic treatments have a significant role in everyday animal care. Some canine parasite infections, even with no or minor effect on the dog itself, are zoonotic.

Cat. No. Product Name CAS No. Information
H9635

INE-963

2640567-43-5

INE-963 is a potent and fast-acting blood-stage antimalarial, demonstrates potent cellular activity against Pf 3D7 with EC50 of 6 nM in Pf growth inhibition assay;INE-963 displays excellent antiplasmodium potency, selectivity against human kinases, and absorption, distribution, metabolism, excretion, and toxicity properties and extended pharmacological profiles.A single dose of INE963 (30 mg/kg) is fully curative in the Pf-humanized severe combined immunodeficient mouse model.INE963 exhibits a high barrier to resistance in drug selection studies and a long half-life (T1/2) across species.

H9408

DSM502

2426616-55-7

DSM502 is a pyrrole-based Dihydroorotate Dehydrogenase (DHODH) inhibitor. DSM502 exhibits nanomolar potency againsts Plasmodium DHODH and Plasmodium parasites, with no inhibition of mammalian DHODHs;DSM502 shows inhibitory activity against P. falciparum DHODH (PfDHODH, IC50=20 nM), P. vivax DHODH (PvDHODH, IC50=14 nM) and Pf3D7 cells (EC50=14 nM), with no inhibition of the human enzyme.

H9254

Amodiaquine dihydrochloride

69-44-3

Amodiaquine dihydrochloride (Amodiaquin dihydrochloride), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor with a Ki of 18.6 nM;Amodiaquine dihydrochloride is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 μM. Anti-inflammatory effect.

H9253

Amodiaquine

86-42-0

Amodiaquine(Amodiaquin), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor with a Ki of 18.6 nM;Amodiaquine is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 μM. Anti-inflammatory effect.

H8556

PfDHODH-IN-2

425629-94-3

PfDHODH-IN-2 is a dihydrothiophenone derivative (Compound 11), is a potent Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor with an IC50 of 1.11 µM;PfDHODH-IN-2 acts as an antimalarial agent and can be used for the research of malaria.

H8522

SJ000025081

421571-66-6

SJ000025081 is a dihydropyridine and acts as a potent antimalarial agent. SJ000025081 results in an obvious suppression of the parasitemia in a murine malaria model infected with P. yoelii.

H8382

Thalifendine chloride

4668-19-3

Thalifendine chloride is a metabolite of Berberine (HY-N0716), with antiplasmodial and antiamoebic activities. Thalifendine chloride shows activity against P. falciparum and E. histolytica with IC50s of 7.91 μM and 116 μM, respectively.

H1494

Tafenoquine succinate

106635-86-3

Tafenoquine succinate (SB-252263, Tafenoquine, WR 238605) is a long-acting, orally active anti-malarial agent to prevent malaria that is holoendemic for Plasmodium falciparum.

H1493

Tafenoquine

106635-80-7

Tafenoquine (SB-252263, Tafenoquine, WR 238605) is a long-acting, orally active anti-malarial agent to prevent malaria that is holoendemic for Plasmodium falciparum.

H1492

SJ-733

1424799-20-1

SJ-733 (SJ000557733;SJ-557733) is an anti-malarial compound that targets ATP4, a cation-transporting ATPase responsible for maintaining low intracellular Na(+) levels in the parasite; displays high potency in vitro against all tested strains of P. falciparum with EC50 of 10-60 nM; kills parasites and the high fitness cost associated with resistance-conferring mutations appear to slow and suppress the selection of highly drug-resistant mutants in vivo; high oral bioavailability

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:
© Copyright 2020 HmoBio. All Rights Reserved. Products are only for research use